These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30340529)

  • 1. Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts.
    Hamanoue S; Suwabe T; Ubara Y; Kikuchi K; Hazue R; Mise K; Ueno T; Takaichi K; Matsumoto K; Morita K
    BMC Nephrol; 2018 Oct; 19(1):272. PubMed ID: 30340529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Influencing Cyst Infection in Autosomal Dominant Polycystic Kidney Disease.
    Suwabe T; Ubara Y; Hayami N; Yamanouchi M; Hiramatsu R; Sumida K; Sawa N; Sekine A; Kawada M; Hasegawa E; Hoshino J; Takaichi K
    Nephron; 2019; 141(2):75-86. PubMed ID: 30513520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues.
    Suwabe T
    Clin Exp Nephrol; 2020 Sep; 24(9):748-761. PubMed ID: 32700112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease.
    Akinci D; Turkbey B; Yilmaz R; Akpinar E; Ozmen MN; Akhan O
    Cardiovasc Intervent Radiol; 2008; 31(5):926-30. PubMed ID: 18196333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics.
    Suwabe T; Araoka H; Ubara Y; Kikuchi K; Hazue R; Mise K; Hamanoue S; Ueno T; Sumida K; Hayami N; Hoshino J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K
    Eur J Clin Microbiol Infect Dis; 2015 Jul; 34(7):1369-79. PubMed ID: 25851811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.
    Akihisa T; Ino A; Egawa H; Kotera Y; Ariizumi S; Oomori A; Yamashita S; Yamamoto Y; Tsuchiya K; Yamamoto M; Nitta K; Mochizuki T
    CEN Case Rep; 2018 Nov; 7(2):307-312. PubMed ID: 29956096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study.
    Suwabe T; Ubara Y; Ueno T; Hayami N; Hoshino J; Imafuku A; Kawada M; Hiramatsu R; Hasegawa E; Sawa N; Saitoh S; Okuda I; Takaichi K
    BMC Nephrol; 2016 Nov; 17(1):170. PubMed ID: 27829402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyst infections in patients with autosomal dominant polycystic kidney disease.
    Sallée M; Rafat C; Zahar JR; Paulmier B; Grünfeld JP; Knebelmann B; Fakhouri F
    Clin J Am Soc Nephrol; 2009 Jul; 4(7):1183-9. PubMed ID: 19470662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
    Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
    Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria.
    Suwabe T; Ubara Y; Sumida K; Hayami N; Hiramatsu R; Yamanouchi M; Hasegawa E; Hoshino J; Sawa N; Saitoh S; Okuda I; Takaichi K
    Clin Exp Nephrol; 2012 Dec; 16(6):892-902. PubMed ID: 22688273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.
    Lantinga MA; de Sévaux RGL; Gevers TJG; Oyen WJG; de Fijter JW; Soonawala D; Zietse R; Salih M; Casteleijn NF; Spithoven EM; Meijer E; Gansevoort RT; Drenth On Behalf Of The Dipak Consortium JPH
    Neth J Med; 2018 Jul; 76(5):226-234. PubMed ID: 30019678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial.
    Gevers TJ; Hol JC; Monshouwer R; Dekker HM; Wetzels JF; Drenth JP
    Liver Int; 2015 May; 35(5):1607-14. PubMed ID: 25369108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome of infected cysts, feces and saliva in patients with autosomal dominant polycystic kidney disease.
    Suwabe T; Morita H; Khasnobish A; Araoka H; Hoshino J
    CEN Case Rep; 2023 Aug; 12(3):304-310. PubMed ID: 36574197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardamonin retards progression of autosomal dominant polycystic kidney disease via inhibiting renal cyst growth and interstitial fibrosis.
    He J; Zhou H; Meng J; Zhang S; Li X; Wang S; Shao G; Jin W; Geng X; Zhu S; Yang B
    Pharmacol Res; 2020 May; 155():104751. PubMed ID: 32151678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Cyst Infection after Colon Endoscopic Mucosal Resection in a Patient with Autosomal Dominant Polycystic Kidney Disease on Maintenance Hemodialysis.
    Shimano S; Tsuda M; Fuyuno S; Arimura Y; Nanishi F
    Intern Med; 2018 Jan; 57(2):219-222. PubMed ID: 29033415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infected cyst in patients with autosomal dominant polycystic kidney disease: Analysis of computed tomographic and ultrasonographic imaging features.
    Oh J; Shin CI; Kim SY
    PLoS One; 2018; 13(12):e0207880. PubMed ID: 30517147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic cyst infection in an autosomal dominant polycystic kidney disease patient diagnosed by right pleural effusion.
    Ihara K; Naito S; Yamaguchi W; Mori Y; Toda T; Rai T; Uchida S; Sasaki S; Matsui N
    Intern Med; 2014; 53(12):1355-9. PubMed ID: 24930657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
    Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease.
    Hiyama L; Tang A; Miller LG
    Am J Kidney Dis; 2006 Jan; 47(1):e9-13. PubMed ID: 16377378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
    Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
    Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.